Copyright © 2007 Elsevier Ltd All rights reserved.
Opinion
The prognosis of latent tuberculosis: can disease be predicted?
Available online 5 April 2007.
References and further reading may be available for this article. To view references and further reading you must purchase this article.
In humans, Mycobacterium tuberculosis persists for long periods in a clinically latent state, creating a huge reservoir of 'silent’ tuberculosis (TB) (roughly one-third of the global population) from which new cases continually arise. A prognostic marker for active TB would enable targeted treatment of the small fraction of infected individuals who are most at risk of developing contagious TB, contributing greatly to TB control efforts. Here, we propose that TB-specific interferon-γ release assays might be useful for identifying individuals with progressive infections who are likely to develop the disease. This might provide an unprecedented advantage for TB control, namely targeted preventive therapy for individuals who are most at risk of developing active contagious TB.
Article Outline
- The global challenge of latent tuberculosis
- TB infection, immune responses and diagnosis
- The tuberculin skin test
- Discovery and characteristics of M. tuberculosis-specific antigens
- The novel specific tests – upgrading diagnosis of TB from induration to IFN-γ
- Correlation between T-cell responses to ESAT-6 and CFP-10, and disease progression in animal models
- Correlation between T-cell responses to ESAT-6 and CFP-10, and clinical outcome
- The potential use of IFN-γ assay as a prognostic test
- Concluding remarks
- Acknowledgements
- References






E-mail Article
Add to my Quick Links

Cited By in Scopus (23)





